Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2009.202 | A Randomized, Double-blind, Multi-center Phase III Study of Brivanib plus Best Supportive Care (BSC) versus Placebo plus BSC in Subjects with Advanced Hepatocellular Carcinoma (HCC) who have Failed or are Intolerant to Sorafenib | Professor Yeo Winnie |
| 2014.365 | A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy | Dr TSANG Chiu Chi |
| 2014.366 | A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy | Dr OZAKI Risa |
| 2014.367 | A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy | Dr CHENG Yuk Lun |
| 2021.714 | A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib |
Prof. LAU Alexander Yuk Lun 劉玉麟 |
| 2003.163 | A Randomized, Double-Blind, Double-Dummy, Parallel Group, Multinational, Clinical Study to Evaluate the Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in Patients with Acute ST-Segment Elevation Myocardial Infarction Receiving Fibrinolytic Therapy | Prof. Woo Kam Sang |
| 2015.471 | A Randomized, Double-Blind, Double-Dummy, Multicenter, Active-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab IV Compared to Adalimumab SC in Subjects With Ulcerative Colitis |
Prof. NG Siew Chien 黃秀娟 |
| 2012.330 | A randomized, double-blind, crossover study to assess the effects of LCZ696 and valsartan in Asian patients with salt-sensitive hypertension | Prof. Tomlinson Brian |
| 2007.463 | A Randomized, Double-blind, Controlled Study of Omegaven for Rescue Treatment of Parenteral Nutrition-Associated Cholestasis (PNAC) in Preterm Infants Requiring Long-term Parenteral Nutrition | Dr Lam Hugh Simon Hung San |
| 2007.462 | A Randomized, Double-Blind, Controlled Study of Omegaven for Prophylaxis against Parenteral Nutrition-Associated Cholestasis (PNAC) in Infants Requiring Prolonged Parenteral Nutrition | Dr Lam Hugh Simon Hung San |
| 2019.333 | A Randomized, Double-Blind, Controlled Phase 3 Study of Cabozantinib in Combination with Nivolumab and Ipilimumab versus Nivolumab and Ipilimumab in Subjects with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma of Intermediate or Poor Risk |
Dr. POON Darren Ming Chun 潘明駿 |
| 2020.168 | A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination with Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma |
Prof. MA Brigette Buig Yue 馬碧如 |
| 2006.194 | A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of Aprepitant for the Prevention of Postoperative Nausea and Vomiting (PONV) | Prof. Gin Tony |
| 2012.417 | A randomized, double-blind, 12-week treatment, parallel-group study to evaluate the efficacy and safety of QMF149 (150 _g/160 _g o.d.) compared with salmeterol xinafoate/fluticasone propionate (50 _g/500 _g b.i.d.) in patients with chronic obstructive pulmonary disease | Dr. Kwan Hoi Yee |
| 2012.415 | A randomized, double-blind, 12-week treatment, parallel-group study to evaluate the efficacy and safety of QMF149 (150 _g/160 _g o.d.) compared with salmeterol xinafoate/fluticasone propionate (50 _g/500 _g b.i.d.) in patients with chronic obstructive pulmonary disease | Prof. Hui Shu Cheong David |
| 2004.225 | A Randomized, Double-Blind Trial to Assess the Safety and Relative Efficacy of CAIV-T against Inactivated Influenza Vaccine in Children 6 | Prof. Sung YT Rita |
| 2003.382 | A Randomized, Double-blind Trial of Telbivudine (LdT) versus Lamivudine in Adults with Decompensated Chronic Hepatitis B and Evidence of Cirrhosis | Prof. CHAN Henry Lik Yuen |
| 2003.061 | A Randomized, Double-blind Trial of Ldt(Telbivudine) versus Lamivudine in Adults with Compensated Chronic Hepatitis B | Dr. Leung Wai Yee Nancy |
| 2007.324 | A Randomized, Double-Blind Study Evaluating Tenofovir Disoproxil Fumarate (DF) Monotherapy versus the Combination of Emtricitabine and Tenofovir DF for the Treatment of Chronic Hepatitis B | Dr. Hui Aric J |
| 2007.322 | A Randomized, Double-Blind Study Evaluating Tenofovir Disoproxil Fumarate (DF) Monotherapy versus the Combination of Emtricitabine and Tennofovir DF for the Treatment of Chronic Hepatitis B | Prof. Chan L.Y. Henry |
| 2015.147 | A randomized, double-blind Phase III study of copanlisib versus placebo in patients with rituximab-refractory indolent non-Hodgkin’s lymphoma (iNHL) – CHRONOS-2 |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2007.386 | A Randomized, Double-Blind Phase 3 Study of Gemcitabine Plus AG-013736 versus Gemcitabine Plus Placebo for the First-Line Treatment of Patients with Locally Advanced, Unrsectable or Metastatic Pancreatic Cancer | Prof. Ma Buig Yue Brigette |
| 2011.050 | A Randomized, Double-Blind Phase 2b Study to Evaluate the Efficacy, Safety, and Tolerability of A-623 Administration in Subjects with Systemic Lupus Erythematosus | Professor Tam Lai-Shan |
| 2004.369 | A Randomized, Double-blind Multicenter Phase 3 Study of Bevacizumab in Combination with Cisplatin and Gemcitabine Versus Placebo, Cisplatin and Gemcitabine in Patients with Advanced or Recurrent Non-Squamous NSCLC, Who have not Received Prior Chemotherapy | Prof. Mok Tony |
| 2016.664 | A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects with Chronic Hepatitis B Virus Infection |
Dr. WONG Lai Hung 黃麗虹 |
| 2006.226 | A Randomized, Double Blind, Placebo-Controlled, Multicenter, Phase III Study Comparing the Activity of Paclitaxel Plus Trastuzumab Plus Lapatinib to Paclitaxel Plus Trastuzumab Plus Placebo in Women with ErbB2 Overexpressing Metastatic Breast Cancer | Prof. Yeo Winnie |
| 2010.479 | A randomized, double blind, placebo controlled, parallel group trial for assessing the clinical benefit of Dronedarone 400mg BID on top of standard therapy in patients with permanent atrial fibrillation and additional risk factors | Prof YU Cheuk-Man |
| 2010.383 | A randomized, double blind, placebo controlled, parallel group trial for assessing the clinical benefit of Dronedarone 400mg BID on top of standard therapy in patients with permanent atrial fibrillation and additional risk factors | Prof Wong Lawrence Ka Sing |
| 2003.111 | A Randomized, Double Blind, Placebo Controlled Trial on the Effect of Rosiglitazone in Reversion of Newly Diagnosed Type 2 Diabetes to Non-Diabetic Status | Prof. Chow Chun Chung Francis |
| 2018.613 | A randomized, double blind, placebo controlled trial of intravenous N-acetylcysteine and oseltamivir versus intravenous 5% dextrose and oseltamivir alone in adults hospitalized with influenza complicated by lower respiratory tract infection |
Prof. HUI David Shu Cheong 許樹昌 |
| 2004.283 | A Randomized, Double Blind Trial of Telbivudine (LdT) versus Lamivudine in Adults with Decompensated Chronic Hepatitis B and Evidence of Cirrhosis | Dr. Leung Wai Yee Nancy |
| 2007.185 | A Randomized, Crossover Study of Medroxyprogesterone Acetate and Diane-35 on Polycystic Ovarian Syndrome Adolescents | Dr. Chan Shing Chee Symphorosa |
| 2022.493 | A Randomized, Controlled, Open-label, Multicenter, Inferentially Seamless Phase 2/3 Study of Ibrutinib in Combination With Rituximab Versus Physician’s Choice of Lenalidomide Plus Rituximab or Bortezomib Plus Rituximab in Participants with Relapsed or Refractory Mantle Cell Lymphoma |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2014.034 | A randomized, controlled trial: transdiagnostic cognitive-behavioural therapy (TCBT) versus non-directive supportive therapy (NDST) for mood-related disorders in a sample of Chinese adults | Professor Leung Patrick |
| 2014.459 | A randomized, controlled trial of the discontinuation of a standard maintenance therapy of oral aminosalicylic acid in ulcerative colitis patients in long-term remission | Prof Ng Siew Chien |
| 2002.143 | A Randomized, Controlled Trial of Photodynamic Therapy with Verteporfin for Choroidal Neovascularization in Pathologic Myopia in Chinese | Prof. Chan Wai Man |
| 2016.353 | A Randomized, Controlled Study of External Counterpulsation for Patients with Impaired Cerebral Autoregulation following Symptomatic Intracranial Artery Stenosis |
Prof. WONG Ka Sing 黃家星 |
| 2003.038 | A Randomized, Controlled Pilot Study to Evaluate the Safety and Efficacy of an Intravitreal Fluorcinolone Acetonide (0.59mg and 2.1mg) Implants in Patients with Clinically Significant Diabetic Macular Edema (BL-420-003) | Prof. Lam Shun Chiu Dennis |
| 2019.096 | A Randomized, Controlled Phase 3 Study of Cabozantinib (XL184) in Combination with Atezolizumab versus Sorafenib in Subjects with Advanced Hepatocellular Carcinoma Who Have Not Received Previous Systemic Anticancer Therapy |
Dr. CHAN Stephen Lam 陳林醫生 |
| 2011.561 | A randomized, controlled clinical trial: the effects of mindfulness-based stress reduction program on the reduction of menopausal symptoms among Chinese peri-menopausal and post-menopausal women in the community | Prof. WONG Samuel Yeung Shan |
| 2014.088 | A randomized, controlled clinical trial: The effects of mindfulness-based stress reduction on burnout and job satisfaction among frontline doctors in Hong Kong | Professor WONG Samuel Yeung Shan |
| 2009.353 | A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy on generalized anxiety disorder and health service utilization in primary care | Dr Wong Samuel Yeung Shan |
| 2011.450 | A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy on chronic insomnia among Chinese patients in the community | Dr. WONG Samuel Yeung Shan |
| 2014.087 | A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy for severe health anxiety among Chinese patients | Professor WONG Samuel Yeung Shan |
| 2012.238 | A randomized, controlled clinical trial: The benefits of a group transdiagnostic cognitive-behavioral therapy (TCBT) with mood-related disorders in Chinese community | Professor Leung Patrick |
| 2006.204 | A Randomized, Comparative, Double-Blind, Parallel-Group, Multicenter, Monotherapy, Study of Pregabalin (Lyrica) and Lamotrigine (Lamictal) in Patients with Newly Diagnosed Partial Seizures | Dr. Kwan Patrick |
| 2008.228 | A Randomized, Comparative Study on Different Heparin Concentrations versus Trisodium Citrate as Inter-Dialytic Catheter Locking Solution for Haemodialysis Patients | Ms Wong Sau Yung Flora |
| 2005.021 | A Randomized, Blinded, Phase IIb Trial of Telbivudine (LdT) versus the Combination of Telbivudine and Valtorcitabine (Val-LdC) in Patients with Chronic Hepatitis B | Dr. Leung Wai Yee Nancy |
| 2005.028 | A Randomized, Blinded, Phase IIb Trial of Telbivudine (LdT) versus the Combination of Telbivudine and Valtorcitabine (Val-LdC) in Patients with Chronic Hepatitis B | Prof. Chan Lik Yuen Henry |
| 2018.526 | A randomized, 24 week, active-controlled, open-label, 3-arm, parallel-group multicenter study comparing the efficacy and safety of iGlarLixi to insulin glargine and lixisenatide in type 2 diabetes mellitus patients insufficiently controlled with oral antidiabetic drug(s) |
Dr. CHOW Elaine Yee Kwan 周怡君 |
Page 217 of 254.